Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Estrogen and related hormone effects, Ferroptosis and cancer prognosis, Cancer-related molecular mechanisms research, and Ovarian cancer diagnosis and treatment.
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
Abstract P4-07-01: Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the TRIO-US B07 trial
Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy
Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells
Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors
PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.
PubMed 2013cited by 102position: middle